TY - JOUR
T1 - Specific binding of factor(s) released by Rous sarcoma virus transformed cells to splenocytes of chickens with Rous sarcomas
AU - Ben Sasson, Z.
AU - Weiss, D. W.
AU - Doljanski, F.
PY - 1974
Y1 - 1974
N2 - Normal and Rous sarcoma virus (RSV) transformed chicken embryo cells shed molecules, presumably macromolecular membrane constituents, that contain glucosamine and choline into their culture media. Such molecules from RSV transformed cells are bound preferentially to spleen cells from chickens bearing RSV induced sarcomas. These lymphoid cells do not preferentially adsorb analogous labeled molecules from normal chicken embryo or from a variety of other normal and neoplastic cell cultures, except those of cells transformed by viruses of the avian leukosis sarcoma complex. Specific binding is not abrogated by inactivation of the lymphoid cells with azide or cyanide. The possible biologic implications of these findings are discussed.
AB - Normal and Rous sarcoma virus (RSV) transformed chicken embryo cells shed molecules, presumably macromolecular membrane constituents, that contain glucosamine and choline into their culture media. Such molecules from RSV transformed cells are bound preferentially to spleen cells from chickens bearing RSV induced sarcomas. These lymphoid cells do not preferentially adsorb analogous labeled molecules from normal chicken embryo or from a variety of other normal and neoplastic cell cultures, except those of cells transformed by viruses of the avian leukosis sarcoma complex. Specific binding is not abrogated by inactivation of the lymphoid cells with azide or cyanide. The possible biologic implications of these findings are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0015976858&partnerID=8YFLogxK
U2 - 10.1093/jnci/52.2.405
DO - 10.1093/jnci/52.2.405
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 4131427
AN - SCOPUS:0015976858
SN - 0027-8874
VL - 52
SP - 405
EP - 412
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 2
ER -